Idhifa
List of products in the National Drug Code with proprietary name idhifa. This medication is used to treat a certain type of blood cell cancer (acute myeloid leukemia-AML). Enasidenib works by helping your bone marrow grow normal blood cells so you will need fewer blood transfusions.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 59572-705 | Idhifa | Enasidenib Mesylate | Tablet, Film Coated | Oral | Celgene Corporation | Human Prescription Drug |
| 59572-710 | Idhifa | Enasidenib Mesylate | Tablet, Film Coated | Oral | Celgene Corporation | Human Prescription Drug |